Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	57.34	53.64	34.09
Graham Fair Price	-5.78	18.36	19.48
PEG	-79.11	0.28	-1.36
Price/Book	0.79	3.48	3.45
Price/Cash Flow	235.61	-22.65	6.75
Prices/Earnings	9.28	-54.15	49.55
Price/Sales	-5.75	2.18	2.32
Price/FCF	235.61	-22.65	6.75
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-28.05	0.11	0.15
Operating Margin	-75.37	< 0.005	0.03
ROA	-0.92	< 0.005	< 0.005
ROE	0.02	-0.02	-7.77
ROIC	0.02	0.18	1027.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.14	-0.20	-27.28
Dividends QOQ	-0.90	-1.00	-10.93
EBIT QOQ	-0.28	-0.74	-168.61
EPS QOQ	-0.36	-1.91	-423.00
FCF QOQ	4.91	-1.29	-73.61
Revenue QOQ	0.05	0.05	-4.93
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	84.01	82.89	-1.34
Inventory Turnover	0.00	283805000.00	100.00
Debt/Capitalization	0.40	0.46	14.55
Quick Ratio	1.12	1.16	3.76
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	31.13	30.55	-1.89
Cash	15.80	7.75	-50.98
Capex	-1.67	-1.13	31.93
Free Cash Flow	15.91	-4.69	-70.54
Revenue	46.35	48.63	4.92
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.31	1.25	-4.02
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.12	15.40	116.46
Naive Interpretation	Member

06 - Financial Health · Weak

Rating